Osmind, a San Francisco, CA-based healthcare technology company building a digital infrastructure for neuropsychiatry, raised $15m in Series A funding.
The round was led by Future Ventures, with participation from existing investor General Catalyst and new investors Tiger Global, Offline Ventures, and Yahoo! co-founder Jerry Yang’s AME Cloud Ventures, as well as angels Joshua Kushner (co-founder of Oscar Health and Thrive Capital), Adrian Aoun (founder of Forward), Jonathan Hirsch (founder of Syapse), Alice Zhang (co-founder of Verge Genomics), Bay Gross (co-founder of Cityblock Health), and Linhao Zhang (co-founder of TrialSpark).
The company, which also announced the addition of Miki Kapoor (co-founder of Verana Health) as an advisor, intends to use the funds to further develop and expand its electronic health record (EHR) and research platform, to make key hires and to expand its research collaborations.
Led by Lucia Huang, CEO, Osmind is building an operating system for neuropsychiatry to enable clinicians and researchers to bring mental health treatments to patients. Its EHR software solution is used by progressive mental health providers to track outcomes, streamline workflows, and increase client engagement for evidence-based practices. It allows clinicians to track measurement-based outcomes for intensive treatment modalities and deliver more tailored care, automates compliance processes for the U.S. FDA and insurance companies, and streamlines patient and practice management. The software also aggregates de-identified real-world data to accelerate research and development of new mental health treatments and diagnostics such as psychedelic medicines, neuromodulation, digital therapeutics, digital phenotyping, and neuroimaging.
FinSMEs
01/07/2021